Cindy Eckert is generally wearing pink, with a matching magenta tint in her hair that gets your attention. And that’s the ...

The initial Rotten Tomatoes score for Melania Trump's new documentary fell short of her husband's approval ratings, opening at 8%. "Melania" hit theaters nationwide Friday, Jan. 30, following the ...

The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...

RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...

Los Angeles-Based Agency Emerges with Diverse Client Portfolio in the Increasingly Integrated Categories of Appearance, Performance, Sexual Health, Longevity and Self-Optimization. LOS ANGELES, Jan.

More than a decade ago, Addyi—marketed as the “female Viagra”—was approved amid political pressure, heavy lobbying, and a lot of hype. The problem then, as now, is simple: the drug barely works and ...

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old. The ...

In 2025, Google is removing reviews at unprecedented rates – and it is not accidental. Our industry analysis of 60,000 Google Business Profiles shows that deletions are being driven by a mix of: ...

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...

The FDA has approved Addyi (flibanserin), a nonhormonal daily pill, to treat low libido in women through age 65. The FDA previously approved Addyi for low sex drive in younger women. Addyi carries a ...